Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now? Drago J, Modi S. Nat Rev Clin Oncol 2024 Nov 6. doi: 10.1038/s41571-024-00963.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Drago J, Modi S. Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now? Nat Rev Clin Oncol 2024 Nov 6. doi: 10.1038/s41571-024-00963.
PMID: 39506069